{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:08:20Z","timestamp":1788923300356,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurom.2025.05.007","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:16:42Z","timestamp":1751426202000},"page":"1070-1079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["High Cervical Intrathecal Targeted Drug Delivery for Refractory Neuropathic Craniofacial Pain"],"prefix":"10.1016","volume":"28","author":[{"given":"Shyam A.","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold W.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adejuyigbe O.","family":"Adaralegbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim M.","family":"Hayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9123-136X","authenticated-orcid":false,"given":"Michael D.","family":"Staudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurom.2025.05.007_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bjae.2020.01.001","article-title":"Diagnosis and management of chronic facial pain","volume":"20","author":"Yao","year":"2020","journal-title":"BJA Educ"},{"key":"10.1016\/j.neurom.2025.05.007_bib2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s40265-023-01927-z","article-title":"Pharmacological management of orofacial pain","volume":"83","author":"Romero-Reyes","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.neurom.2025.05.007_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.36076\/ppj\/2019.22.447","article-title":"Neurostimulation for the treatment of chronic head and facial pain: a literature review","volume":"22","author":"Antony","year":"2019","journal-title":"Pain Physician"},{"key":"10.1016\/j.neurom.2025.05.007_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1227\/neu.0000000000002578","article-title":"Congress of neurological surgeons systematic review and evidence-based guidelines for occipital nerve stimulation for the treatment of patients with medically refractory occipital neuralgia: update","volume":"93","author":"Staudt","year":"2023","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neurom.2025.05.007_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000509574","article-title":"Peripheral nerve stimulation for facial pain using conventional devices: indications and results","volume":"35","author":"Winfree","year":"2020","journal-title":"Prog Neurol Surg"},{"key":"10.1016\/j.neurom.2025.05.007_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/rapm-2023-104961","article-title":"Intrathecal cervical analgesia for cancer pain: a 12-year follow-up study in a comprehensive cancer center","volume":"49","author":"Dupoiron","year":"2024","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.neurom.2025.05.007_bib7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/pm\/pnv058","article-title":"Successful management of corneal neuropathic pain with intrathecal targeted drug delivery","volume":"17","author":"Hayek","year":"2016","journal-title":"Pain Med"},{"key":"10.1016\/j.neurom.2025.05.007_bib8","first-page":"1213","article-title":"Intrathecal drug delivery system in prepontine cistern for patients with intractable craniofacial cancer pain: a multicenter retrospective study","volume":"10","author":"Long","year":"2024","journal-title":"Anesth Analg"},{"key":"10.1016\/j.neurom.2025.05.007_bib9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1399-6576.2009.01989.x","article-title":"High intrathecal bupivacaine for severe pain in the head and neck","volume":"53","author":"Lundborg","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.neurom.2025.05.007_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1034\/j.1399-6576.1999.430613.x","article-title":"Clinical experience using intrathecal (IT) bupivacaine infusion in three patients with complex regional pain syndrome type I (CRPS-I)","volume":"43","author":"Lundborg","year":"1999","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.neurom.2025.05.007_bib11","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/pm\/pnaa104","article-title":"Comparative effectiveness of targeted intrathecal drug delivery using a combination of bupivacaine with either low-dose fentanyl or hydromorphone in chronic back pain patients with lumbar postlaminectomy syndrome","volume":"21","author":"Ade","year":"2020","journal-title":"Pain Med"},{"key":"10.1016\/j.neurom.2025.05.007_bib12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/pm\/pnac195","article-title":"Efficacy of continuous intrathecal infusion trialing with a mixture of fentanyl and bupivacaine in chronic low back pain patients","volume":"24","author":"Hayek","year":"2023","journal-title":"Pain Med"},{"key":"10.1016\/j.neurom.2025.05.007_bib13","first-page":"561","article-title":"Intrathecal hydromorphone and bupivacaine combination therapy for post-laminectomy syndrome optimized with patient-activated bolus device","volume":"17","author":"Hayek","year":"2016","journal-title":"Pain Med"},{"key":"10.1016\/j.neurom.2025.05.007_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1213\/00000539-200208000-00035","article-title":"The mechanisms of intracranial pressure modulation by epidural blood and other injectates in a postdural puncture rat model","volume":"95","author":"Kroin","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.neurom.2025.05.007_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bjophthalmol-2014-306280","article-title":"Ocular neuropathic pain","volume":"100","author":"Rosenthal","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurom.2025.05.007_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bjophthalmol-2014-306057","article-title":"Dry eye symptom severity and persistence are associated with symptoms of neuropathic pain","volume":"99","author":"Galor","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurom.2025.05.007_bib17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40123-021-00358-x","article-title":"Neuropathic corneal pain following LASIK surgery: a retrospective case series","volume":"10","author":"Moshirfar","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.neurom.2025.05.007_bib18","doi-asserted-by":"crossref","first-page":"e1379","DOI":"10.1016\/j.wneu.2019.03.107","article-title":"Percutaneous trigeminal nerve stimulation for persistent idiopathic facial pain: a case series","volume":"126","author":"McMahon","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.neurom.2025.05.007_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/neuros\/nyaa065","article-title":"Percutaneous trigeminal stimulation for intractable facial pain: a case series","volume":"87","author":"Texakalidis","year":"2020","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neurom.2025.05.007_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000509983","article-title":"Cervical spinal cord stimulation for facial pain","volume":"35","author":"Jones","year":"2020","journal-title":"Prog Neurol Surg"},{"key":"10.1016\/j.neurom.2025.05.007_bib21","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1093\/brain\/awab189","article-title":"Motor cortex stimulation for chronic neuropathic pain: results of a double-blind randomized study","volume":"144","author":"Hamani","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neurom.2025.05.007_bib22","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.neurom.2024.05.003","article-title":"Beta oscillations in the sensory thalamus during severe facial neuropathic pain using novel sensing deep brain stimulation","volume":"27","author":"Lopez Ramos","year":"2024","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2025.05.007_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11916-003-0037-x","article-title":"Convergence of cervical and trigeminal sensory afferents","volume":"7","author":"Piovesan","year":"2003","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.neurom.2025.05.007_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000542-200607000-00027","article-title":"Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs","volume":"105","author":"Bernards","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neurom.2025.05.007_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003088-199222050-00001","article-title":"Intrathecal drug administration. Present use and future trends","volume":"22","author":"Kroin","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.neurom.2025.05.007_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0885-3924(95)00099-2","article-title":"Intraspinal morphine for chronic pain: a retrospective, multicenter study","volume":"11","author":"Paice","year":"1996","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.neurom.2025.05.007_bib27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/j.1526-4637.2011.01232.x","article-title":"Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients","volume":"12","author":"Veizi","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.neurom.2025.05.007_bib28","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2147\/JPR.S193746","article-title":"Near-resolution of persistent idiopathic facial pain with low-dose lumbar intrathecal ziconotide: a case report","volume":"12","author":"Staub","year":"2019","journal-title":"J Pain Res"},{"key":"10.1016\/j.neurom.2025.05.007_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00482-011-1080-x","article-title":"Experience in treatment of patients with neuropathic facial pain using ziconotide","volume":"25","author":"Lux","year":"2011","journal-title":"Schmerz"},{"key":"10.1016\/j.neurom.2025.05.007_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ner.12270","article-title":"Ziconotide combination intrathecal therapy for noncancer pain is limited secondary to delayed adverse effects: a case series with a 24-month follow-up","volume":"18","author":"Hayek","year":"2015","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2025.05.007_bib31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00000542-200609000-00025","article-title":"Opiate pharmacology of intrathecal granulomas","volume":"105","author":"Allen","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neurom.2025.05.007_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1525-1403.2009.00259.x","article-title":"Intrathecal inflammatory masses: is the yearly opioid dose increase an early indicator?","volume":"13","author":"Duarte","year":"2010","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2025.05.007_bib33","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/ner.12481","article-title":"Primary hydromorphone-related intrathecal catheter tip granulomas: is there a role for dose and concentration?","volume":"19","author":"Veizi","year":"2016","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2025.05.007_bib34","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1227\/01.NEU.0000359223.11215.D9","article-title":"Surgical management of spinal catheter granulomas: operative nuances and review of the surgical literature","volume":"65","author":"Zacest","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neurom.2025.05.007_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/sni.sni_80_17","article-title":"Intrathecal catheter-associated inflammatory mass in a neurofibromatosis type-1 patient receiving fentanyl and bupivacaine","volume":"8","author":"Southwell","year":"2017","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.neurom.2025.05.007_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/rapm-2024-105597","article-title":"Recurrent intrathecal catheter-tip granuloma formation on a replaced system delivering low dose\/concentration fentanyl and bupivacaine: a case report","volume":"50","author":"Feldheim","year":"2025","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.neurom.2025.05.007_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0730-725X(99)00142-3","article-title":"Origin of subarachnoid cerebrospinal fluid pulsations: a phase-contrast MR analysis","volume":"18","author":"Henry-Feugeas","year":"2000","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.neurom.2025.05.007_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3325\/cmj.2014.55.337","article-title":"Cerebrospinal fluid physiology: visualization of cerebrospinal fluid dynamics using the magnetic resonance imaging time-spatial inversion pulse method","volume":"55","author":"Yamada","year":"2014","journal-title":"Croat Med J"},{"key":"10.1016\/j.neurom.2025.05.007_bib39","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/ner.12963","article-title":"Characterization of effect of repeated bolus or continuous intrathecal infusion of morphine on spinal mass formation in the dog","volume":"22","author":"Hildebrand","year":"2019","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2025.05.007_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1053\/eujp.2001.0255","article-title":"Outcome of intrathecal opioids in chronic non-cancer pain","volume":"5","author":"Roberts","year":"2001","journal-title":"Eur J Pain"},{"key":"10.1016\/j.neurom.2025.05.007_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0090-3019(01)00353-6","article-title":"Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy","volume":"55","author":"Kumar","year":"2001","journal-title":"Surg Neurol"},{"key":"10.1016\/j.neurom.2025.05.007_bib42","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1526-4637.2010.00876.x","article-title":"Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up","volume":"11","author":"Atli","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.neurom.2025.05.007_bib43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1067\/S1526-5900(03)00730-2","article-title":"Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain","volume":"4","author":"Rauck","year":"2003","journal-title":"J Pain"},{"key":"10.1016\/j.neurom.2025.05.007_bib44","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00000542-200308000-00030","article-title":"Epidural, cerebrospinal fluid, and plasma pharmacokinetics of epidural opioids (part 2): effect of epinephrine","volume":"99","author":"Bernards","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neurom.2025.05.007_bib45","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.spmd.2004.02.002","article-title":"Pharmacology of intrathecally administered agents for treatment of spasticity and pain","volume":"1","author":"Hayek","year":"2003","journal-title":"Semin Pain Med"},{"key":"10.1016\/j.neurom.2025.05.007_bib46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10928-010-9184-y","article-title":"Understanding pharmacokinetics using realistic computational models of fluid dynamics: biosimulation of drug distribution within the CSF space for intrathecal drugs","volume":"37","author":"Kuttler","year":"2010","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.neurom.2025.05.007_bib47","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.3390\/jcm10173788","article-title":"Spinal cord motion in degenerative cervical myelopathy: the level of the stenotic segment and gender cause altered Pathodynamics","volume":"10","author":"Wolf","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.neurom.2025.05.007_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000100205","article-title":"Chronic intrathecal baclofen administration in severe spasticity","volume":"54\u201355","author":"Broseta","year":"1990","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.neurom.2025.05.007_bib49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.13004\/kjnt.2022.18.e18","article-title":"Intrathecal morphine infusion for trigeminal deafferentation pain following percutaneous intervention for unexplained facial pain: a case report","volume":"18","author":"Son","year":"2022","journal-title":"Korean J Neurotrauma"},{"key":"10.1016\/j.neurom.2025.05.007_bib50","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00000542-199602000-00003","article-title":"Continuous intracisternal and high cervical intrathecal bupivacaine analgesia in refractory head and neck pain","volume":"84","author":"Appelgren","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neurom.2025.05.007_bib51","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1080\/10717544.2022.2134507","article-title":"Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical note","volume":"29","author":"Zhou","year":"2022","journal-title":"Drug Deliv"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715925002247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715925002247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:25:15Z","timestamp":1760538315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715925002247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1094715925002247"],"URL":"https:\/\/doi.org\/10.1016\/j.neurom.2025.05.007","relation":{},"ISSN":["1094-7159"],"issn-type":[{"value":"1094-7159","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Cervical Intrathecal Targeted Drug Delivery for Refractory Neuropathic Craniofacial Pain","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurom.2025.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Neuromodulation Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}